Table 4.
Dietary phytochemicals and changes in miRNA levels.
Dietary Agent | Disease Type | miRNA | Concentration | Ref. |
---|---|---|---|---|
| ||||
Apigenin | Lung cancer cells | miR138, miR-125a-5p | 25–100μM | 230 |
Neuroblastoma cells | miR-138 | 100 μM | 229 | |
| ||||
Curcumin | Bladder cancer cells | miR-203 | 1–20 μM | 231 |
Lung cancer cells | miR-320, miR-26a, let-7i, miR-130a, mir-16, miR-125b,miR-23a, miR-27b, miR-155, miR-625, miR-576-3p, miR-186, miR-9 | 10–50 μM | 232 | |
Leukemia | miR-15a, miR-16-1 | 5–20 μM | 233 | |
Pancreatic cancer cells | miR-103, miR-140, miR-146b, miR-148, miR-15b,miR-181a, miR-181b, miR-181d, miR-195, miR-196a,miR-199a, miR-19a,miR-204, miR-20a, miR-21, miR-22miR-23a,b, miR-24, miR-25, miR-26a, miR-27a, miR-34a,miR-374, miR-510, miR-7, miR-92, miR-93, miR-98 | 10 μmol/L | 234 | |
| ||||
EGCG | Neuroblastoma cells | miR-92, miR-93,miR 106b, miR-34a, miR-99a | 25–100 μM | 228 |
Hepatocellular carcinoma cells | miR-467b, miR-487b, miR-197, miR-805, miR-374, let-7f, miR-350, miR-24-1, miR-137, miR-335-3p, let-7a, miR-222, miR-26b, miR-30c-1, let-7d, miR-98, miR-30c, miR-30b, miR-32, miR-674, miR-532-5p, let-7g, miR-18a, miR-192, miR-302d, miR-30b, miR-802, let-7e,miR-322, miR-720, miR-146b, miR-340-3p, miR-185, miR-425, miR-10a, miR-126-5p, miR-101a, miR-30e, let-7c, miR-141, miR-33, miR-29a, miR-199b, miR-450a-5p, miR-21, miR-23a, miR-101b, miR-148a, miR-193, miR-23b, miR-107, miR-140, miR-551b, miR-466c-5p, miR-106a, miR-590-3p, miR-875-3p, miR-224, miR-292-5p, miR-678, miR-469, let-7b, miR-463miR-574-3p, miR-201, miR-290-3p, miR-181a, miR-302a, miR-429, miR-133a, miR-190b, miR-710, miR-135b, miR-296-5p, miR-191, miR-188-5p, miR-298, miR-181a-1, miR-466g, miR-26b, miR-466f-3p, miR-29b, miR-1224, miR-291b-5p, miR-324-5p, miR-486, miR-128, miR-450b-3p, miR-135a, miR-294, miR-671-5p, miR-878-3p, miR-801, miR-370, miR-1, miR-494, miR-133b |
100 μM | 235 | |
Lung carcinoma | let-7c, miR210 | 100 μM | 235 | |
Pancreatic cancer cells | let-7c | 100 μM | 235 | |
Colon carcinoma cells | miR-27a, miR-20A, miR-17-5P, miR-21 | 5–30 μM | 236 | |
| ||||
Genistein | Ovarian cancer cells | miR-100, miR-122a, miR-125b, miR-126, miR-135, miR-135b, miR-136, miR-137, miR-141, miR-152,miR-190, miR-196a, miR-196b, miR-204, miR-205, miR-206, miR-217, miR-22, miR-296, miR-30a-3p, miR-30a-5p, miR-331, miR-335, miR-342, miR-362, miR-449b, miR-454, miR-497, miR-500, miR-501, miR-503, miR-515, miR-517c, miR-532, miR-565, miR-578, miR-584, miR-585, miR-590, miR-595, miR-625, miR-647, miR-7, miR-765, miR-766 | 5 μM | 136 |
Pancreatic cancer cells | miR-200 | 50 μM | 137 | |
| ||||
Indole-3 carbinol Diindolylmethane | Breast cancer cells | miR34a | 25 μM | 137 |
Prostate cancer cells | miR34a | 10 μM | 238 | |
miR-21 | 30–60 μM for cells 5mg/kg (mice) |
237 | ||
Mouse lung tumors | miR-21, mir-31, miR-130a, miR-146b and miR-377 | 100–150 μM | 239 | |
| ||||
Lycopene | Hepa 1–6 cells (hepatic cells) | miR-21 | 0.05% (fed orally to mice) | 240 |
| ||||
Diallyl disulphide | Endothelial progenitor cells | miR-221 | 0–10 μM (10mg/kg/day) | 241 |
Breast Cancer | miR34a | 25–400 μM | 242 | |
| ||||
Resveratrol | Prostate cancer cells from lymph node | miR-1224-5p, miR-1228, miR-1231, miR-1246, miR-1260, miR-1267, miR-1268, miR-129, miR-1290, miR-1308, miR-1469, miR-149, miR-150, miR-152, miR-15a, miR-17, miR-1825, miR-185, miR-18b, miR-1908, miR-1915, miR-197, miR-1972, miR-1973, miR-1974, miR-1975, miR-1977, miR-1979, miR-20a, miR-20b, miR-24, miR-296-5p, miR-483-5p, miR-513a-5p, miR-548q, miR-572, miR-575, miR-612, miR-638, miR-654-5p, miR-659, miR-671-5p, miR-7, miR-762, miR-764, miR-874, miR-92b, miR-939 | 50 μM | 243 |
Prostate cancer cells | miR-101, miR-106a, miR-106b, miR-1274b, miR-136, miR-141, miR-145, miR-17, miR-182, miR-1826, miR-200b, miR-200c, miR-20a, miR-20b, miR-21, miR-214, miR-221, miR-222, miR-302c, miR-375, miR-378, miR-720, miR-768-3, miR-93 | 5–100 μM | 244 | |
Colorectal cancer cells | miR-1, miR-100-1/2, miR-102, miR-103-1, miR-103-2, miR-146a, miR-146b-5p, miR-16-0, miR-17, miR-181a2, miR-194-2, miR-196a1, miR-205, miR-206, miR-21, miR-23a, miR-23b, miR-25, miR-26a, miR-29c, miR-30a-3p, miR-30c-1, miR-30d, miR-30e-5p, miR-323, miR-340, miR-363-5p, miR-424, miR-494, miR-497, miR-560, miR-560, miR-565, miR-565, miR-572, miR-574, miR-594, miR-615, miR-622, miR-629, miR-631, miR-638, miR-639, miR-657, miR-659, miR-663, miR-801, miR-92a-2 | 50 μM | 245 | |
| ||||
Luteolin | Prostate cancer cells | miR-630 | 0–10 μM | 246 |
Gastric cancer cells | miR-34a | 5–50 μM | 247 | |
| ||||
Phenethyl isothiocyanate | Prostate cancer cells | miR-141 | 0–20 μM | 248 |